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CHAPTER I 
 
MATERIALS AND METHODS 
 
Acquisition of Hoof Lamellar Samples 
 
This has been described (Johnson, Kreeger et al. 2000; Loftus, Belknap et 
al. 2006). For BWE and starch induced laminitis, horses were anesthetized 
(Johnson, Kreeger et al. 2000; Loftus, Belknap et al. 2006; Loftus, Belknap et al. 
2007), the distal aspect of the right fore limb disarticulated from each horse at the 
level of the metacarpophalangeal joint and acquisition of lamellar tissue from 
each hoof accomplished within 5 minutes using a band saw, Horses were 
euthanized immediately after removal of the hoof. For clinical samples, lamellae 
were isolated with 10 minutes of euthanasia. Blocks of lamellar tissue 
(approximately 5 mm X 5 mm) were obtained by sharp dissection and either 
placed in 10% formalin or immediately frozen by submersion in liquid nitrogen 
and stored at -80° C until processed. In all cases blocks of lamellar tissue were 
obtained from the mid-point between the level of the coronary band 
and the ground- bearing surface on the dorsal aspect of the hoof. 
BWE Samples 
Archived samples of laminar tissue from previous studies (Waguespack, 
Cochran et al. 2004; Waguespack, Kemppainen et al. 2004; Black, Lunn et al. 
2006) were used. Briefly, healthy horses were administered either 6 L of water as 
a control (n = 10) or BWE (n = 10) (2 g heartwood/kg body weight, prepared as 
described (Eaton et al., 1995) via  nasogastric intubation. Horses were euthanized 
at 1.5 hours post-induction, after a 30 % drop in the baseline leukocyte count (3 to 
 2 
5 hours after BWE), or at the onset of Obel grade 1 lameness (typically around 
10-12 hours after BWE). All animal protocols were approved by the Institutional 
Animal Care and Use Committees (IACUCs) of the Ohio State University or 
Auburn University. 
CHO Samples 
Carbohydrate-treated animals: Archived samples of lamellae from a 
previous study (Johnson, Kreeger et al. 2000) were used. Briefly, healthy horses 
were administered starch at a concentration of 17.6 grams of starch per kg of body 
weight via a nasogastric tube as described or water as a control (Johnson, Kreeger 
et al. 2000). Horses were euthanized when they developed Obel grade III laminitis 
(experimental group) typically 36 to 48 hours following administration of starch, 
or at equivalent time points for control animals. All animal protocols were 
approved by the IACUC of the University of Missouri. 
Clinical Samples 
These were obtained from horses euthanized at the University of Missouri 
School of Veterinary Medicine Equine Clinical Center. Animals were grouped as 
follows: Those presenting “acute clinical laminitis” had not previously shown 
signs of this disease; those presenting “chronic clinical laminitis” had a history of 
the condition and were chronically lame but not in an acute episode; those 
presenting “chronic aggravated laminitis” had a history of the condition and were 
experiencing a debilitating episode. Control clinical samples were from horses 
euthanized for a variety of conditions unrelated to laminitis and had no history of 
laminitis. 
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RNA Isolation and cDNA Synthesis 
Black Walnut Extract laminae were pulverized using a tissue 
homogenizer. Total RNA was then extracted from the tissue using the 
guanidinium isothiocynate method as described in (Alfandari, Whittaker et al. 
1995). RNA was quantified at OD260 and 1µg of each sample was run on a 1% 
agarose gel with 0.1µg/ml ethidium bromide to ensure RNA integrity. Using 0.5 g 
of frozen laminae tissue and 10 ml of guanidinium isothiocynate solution we 
obtained 25-160 µg of RNA depending on sample. 10 µg of this RNA was treated 
by RNAse free DNAse 1 (Promega) prior to cDNA synthesis reaction using oligo 
dT and MMLV reverse transcriptase in a 50 µl reaction volume (Promega). 
Before addition of the MMLV, 10 µl of the reaction mix was removed and saved 
for the no-RT control PCR and to control for complete genomic DNA digestion. 
This cDNA was then diluted in sterile H2O 1:10 and 1 µl of this dilution was used 
for each 20 µl RT-qPCR reaction. Total RNA was also extracted from frozen 
equine testis tissue using a tissue homogenizer. Using 100 mg of tissue we were 
able to extract approximately 70 µg of total RNA. cDNA synthesis was done 
using the same method used for the BWE treated animals. The cDNA for the 
clinical and Carbohydrate Overload samples were obtained as previously 
described (Waguespack, Cochran et al. 2004; Waguespack, Kemppainen et al. 
2004). 
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RT-qPCR and Data Processing 
The quantitative PCR data was obtained using the Roche Lightcycler 2.0. 
Each primer set was tested in order to determine the melting curve of the 
amplification product which was then used to determine the optimal fluorescence 
reading temperature. The reading temperature for each primer set was selected at 
2-4°C before complete dissociation of the specific amplification product. 
Following each reaction, PCR products were run on 2% agarose gel with 
0.1µg/ml ethidium bromide to confirm that the proper size fragment was 
amplified for each product. Cycling conditions were as follows: 1 cycle at 95°C 
for 5 minutes, 45 cycles of 60°C for 30s, 72°C for 30s, single fluorescence 
reading at predetermined temperature, 95° C for 15s, 1 cycle for melting curve 
using a stepwise increase of temperature from 65°C to 95°C with a constant 
fluorescence reading. In order to determine the most stable control gene for 
comparison using the ∆∆Ct method we used the GeNorm computer program 
(Ghent University). We tested the expression patterns of Glyceraldeyhde 3-
phosphate dehydrogenase (GAPDH), β-Actin, and α2-Microglobulin and the 
most stable control gene in both the BWE and CHO/Clinical laminitis sets was 
determined to be GAPDH and was used as our control. Each sample was then run 
in triplicate and their Ct values were averaged and analyzed using the ∆∆Ct 
method of analysis (Livak and Schmittgen 2001). The results from this analysis 
for the control animals were averaged separately for animals from the BWE 
subset (n=3) and animals from the CHO/Clinical laminitis subsets (n=4). 
Experimental results for each animal and gene were then divided by the average 
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of the control animals to produce a final fold increase controlled both to GAPDH 
and to animals that did not show signs of laminitis. 
Cloning of ADAMs 
Testis cDNA was used as template to amplify ADAM related 
metalloprotease as well as TIMPs by RT-PCR using the minimally degenerated 
oligonucleotides found in Table 3. Cycling conditions for all genes were: 1 cycle 
at 95°C for 4 minutes, 35 cycles of 94°C 30 seconds, 55°C 30 seconds, 72°C 1 
minute, 1 cycle 72°C for 5 minutes. Using equine testis cDNA as a template each 
genes correct product size was amplified. These PCR products were cloned into 
pCR4-TOPO (Invitrogen) and sequenced either by the university of 
Massachusetts Amherst genomic facility or the Genewiz company. These 
sequences were then analyzed using BLAST and upon confirmation of each genes 
identity, specific primers were designed for real time quantitative PCR. 
Degenerate oligonucleotides were also employed to clone full-length constructs of 
both MMP9 and ADAM-TS4. 
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CHAPTER II  
 
HISTORY OF LAMINITIS 
 
Introduction to Laminitis 
 
Laminitis is defined as an inflammation of the laminae, especially in the 
hoof of the horse (Merriam Webster). It is a disease that has affected the equine 
industry since as early as 350 B.C. when Aristotle termed it ‘Barley Disease’. 
Since this time there have been many treatments developed for the disease, 
including treatment with anti-inflammatory drugs, NSAIDs, and ice baths. All of 
these treatments are capable of helping to treat the symptoms, but none target the 
underlying systemic issues. In recent years work has been done to understand 
exactly how the equine hoof responds to laminitis and what structures are being 
affected. It is critical to determine what the molecular pathologies are during the 
initiating and developmental stages of laminitis in order to develop a treatment 
that has any potential for success.  
 
Anatomical Evolution of the Horse 
 
The horse evolved over a 60 million years into an animal that man kind 
has relied on to help spread onto every corner of the planet. The original animal 
was termed Hyracotherium and its unique characteristics allowed for its 
development into the animal that we now know as the modern Equus Caballus 
(Short 1975).  The forelimbs of the modern horses predecessor had five padded 
toes, named p1 through p5, while the hind limbs had only three padded toes, 
named p1 through p3.  
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As evolution selected for the strongest of this animals traits, the forelimbs 
drastically changed. Over a period of about 50 million years the horse had 
evolved into an animal known as Pliohippus which had evolved such that the only 
weight bearing toe was p3 (Short 1975). Over the next 10 million years the horse 
evolved slightly further and the only clearly digit that is visible to date is the p3 
bone. Both p4, the metatarsal bone, and p2, the metacarpal bone are still present 
and are termed the splint bones. These bones play an important role in supporting 
the knee and hock in Equus Caballus (Short 1975).  
 Evolution has clearly shown that perhaps the most important bone in a 
horses body is the p3 digit. This bone is solely responsible for the support of the 
animals entire mass, which averages around 1000 pounds. It also has to be taken 
into account that the force of impact on the forelimbs greatly exceeds that of the 
animals body weight. Inflammation and degradation of the sensitive laminae, 
which connects the p3 bone to the inner wall of the hoof is the major cause of 
laminitis and a great deal of work has been done to study how this connection is 
made. The connection between the keratinized hoof wall and the p3 digit can be 
divided into three sections, the coronary papillae, secondary lamellae, and 
terminal papillae, as seen in Figure 1.  
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Figure 1: Anatomy of the Hoof Wall (Daradka and Pollitt 2004; Pollitt and 
Daradka 2004; Keller, Galloway et al. 2006) 
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 The corium, located at the top of the hoof wall is a highly vascular area 
consisting of tough connective tissue with a network of arteries, veins, and 
capillaries. It is essential for nourishment of the hoof and it plays a major role in 
the connection of the p3 digit with the inner hoof. Each coronary papillae that 
shoots out from the corium is responsible for providing nutrients to an individual 
hoof wall tubule (Kasapi and Gosline 1998). As epidermal basal cells produce 
keratinocytes they are targeted in a downward path towards the bottom of the 
hoof wall (Daradka and Pollitt 2004). This is how the hoof is able to grow 
constantly through the life of a horse.  
 Moving distally in the hoof, the next major region of importance for 
support is the secondary lamellae. Within this region is the stratum lamellatum 
which has several hundred projecting primary epidermal lamellae. These 
epidermal lamellae are shaped like long rectangles and they are incorporated into 
the stratum lamellatum like a key in a lock.  It is believed that the structure of the 
epidermal lamellae is intended to increase the surface area of the lamellae which 
suggests its potential role in the suspension of the animals weight (Sarratt and 
Hood 2005). Overall the entire surface area of the inner hoof wall has been 
calculated to average 1.3m
2 
which is equal to that of the surface area of a humans 
entire skin (Sarratt and Hood 2005). With this amazing surface area the animal is 
able to deal with the great deal of stress placed on the hoof in both active and 
stationary activities.  
 In the location where the epidermis and dermis meet, there is a very tough 
sheet of extracellular matrix known as the basement membrane. This structure 
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attaches the cells of the lamellar epidermis to type I collagen on the surface of the 
p3 bone (Pollitt and Daradka 1998). Filaments of collagen IV run in the dorsal-
ventral axis and are covered in laminin, these two together form the laminin densa 
(Pollitt 1994). Type I collagen and laminin densa interweave and are found at a 
high concentration in the basement membrane (Pollitt 1994) which is not 
surprising considering the weight bearing load of the hoof.  
 
Conflicting Hypothesis on the Cause of Laminitis 
 
 At this point in time there are two main hypotheses on how laminitis 
manifests itself. The first hypothesis suggests that constriction of the blood 
vessels supplying nutrients to the collagen rich laminae become restricted, 
causing cell death in the laminae (Hood 1999). The second hypothesis proposes 
that a local inflammation of the laminae recruits leucocytes that activate MMPs 
and initiate the destruction of the laminae (Johnson, Tyagi et al. 1998; Mungall, 
Pollitt et al. 1998). This second hypothesis has been supported in recent findings 
where horses induced with Black Walnut Extract showed proteolytic fragments of 
collagen in their blood (Johnson, Kreeger et al. 2000). Other recent work has 
shown an infiltration of neutrophils into the laminae which correlates with an 
increased level of MMP-9 protein (Loftus, Belknap et al. 2006). This would most 
likely occur because neutrophils have been observed to store MMP-9 in their 
tertiary granules (Chakrabarti and Patel 2005).  
 Regardless of the initial triggering mechanism the end result is always the 
destruction of the collagen rich laminae. It is interesting to note that both ischemia 
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and inflammation can result in the activation of metalloproteases capable of 
degrading the collagen rich laminae.  
Natural Laminitis Description 
  
Causes of natural laminitis have such a great range that it is very hard to 
pin point what started the disease. Many of the potential causes are outlined in 
Table 1.  
Cause Reasoning 
Carbohydrate 
Overload 
If a horse is given grain in excess or eats grass under 
stress and has accumulated excess of non-structural 
carbohydrates it may be unable to digest the 
carbohydrates in the foregut. Excess carbohydrates 
move to the hindgut and ferment in the cecum. This 
causes an increase in lactic acid levels and proliferation 
of bacteria capable of producing endotoxins. Endotoxins 
are absorbed into the bloodstream resulting in a 
decreased circulation, especially in the hoof. 
Insulin Resistance Not fully understood but may be triggered by sugar and 
starch imbalance.  
Nitrogen 
Compound 
Overload 
Rapid fluctuation of non-protein nitrogens. The natural 
metabolic processes become overloaded resulting in 
liver disturbance and toxic imbalance. 
Hard Ground Hard surfaces increase concussion on horses feet, 
potentially causing laminitis. 
Lush Pastures Same concept as carbohydrate overload. 
Colic Release of endotoxins into the blood stream 
 
Table 1: Causes of Laminitis 
 
 The progression of laminitis has been divided into four stages. The 
developmental (prodromal) stage begins when an initial injury occurs until there 
is an appearance of the clinical signs of laminitis (Hood, Grosenbaugh et al. 
1993). The duration of this phase depends mainly on what factor caused the initial 
injury, for example Black Walnut ingestion will cause a shorter developmental 
stage than colic. The next stage is the acute phase lasting from when clinical signs 
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are observed until there is evidence of mechanical collapse of the distal phalanx 
within the hoof capsule, or 72 hours, whichever comes first (Hood 1999). If there 
are clinical signs over 72 hours but there is not structural failure of the hoof the 
disease is classified as sub acute. Once the horse develops structural failure, for 
example rotation or sinking of the distal phalanx, then the disease is considered in 
the chronic phase.  
 These stages are also linked to the Obel grading system of laminitis,  
 
which was developed by Obel in 1948 (Obel N. Studies on the histopathology of 
acute laminitis. Uppsala, Sweden: Almquist and Wiskells, 1948.). This system 
grades a horse symptom from 1 through 4, with 4 being the worst prognosis. At 
grade 1 a horse alternately and incessantly lifts the feet, lameness is not evident at 
a walk, but at a trot a short stilted gait is noticed. Grade 2 is defined as a horse 
that walks with a stilted gait but can still have a foot lifted. The main difference at 
grade 3 is that a horse moves much more reluctantly and will resist lifting of a 
foot. At the most severe grade, grade 4, the horse refuses to move unless forced to 
do so. 
Induction models of Laminitis 
 
 Development of an experimental model for natural laminitis is essential in 
attempting to study the molecular and pathological events leading up to the 
degradation of the laminae. There are two current models used for the 
experimental induction of laminitis, these are the Black Walnut (BWE) and 
Carbohydrate Overload (CHO) models. Each model has its own benefits and 
drawbacks, which have been explored extensively since their discovery.  
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Induction of laminitis by treatment of Black Walnut extract via nasogastric 
intubation was developed in the 1980’s (Minnick, Brown et al. 1987). It was 
known in the horse industry that animals exposed to shavings from the black 
walnut tree, Juglans Nigra, became laminitic. In order to confirm this hypothesis 
Minneck soaked 2g/kg of black walnut shavings in water and administered it to 
the animals via nasogastric intubation. In this experiment, horses developed 
edema of the coronary band and 8/10 horses demonstrated clinical signs of 
laminitis within 12 hours of administration (Minnick, Brown et al. 1987). 
Measurements revealed at least a 30% decrease in white blood cell counts 4 hours 
after administration of BWE, and an increase in white blood cells, packed cell 
volume, and hyperglycemia starting at 8 hours post administration (Galey, 
Whiteley et al. 1991). These changes in white blood cells are similar to that of 
animals with endotoxemia but when blood from BWE induced horses was 
analyzed for endotoxins there were none present (Eaton, Allen et al. 1995).  
 Another aspect of natural laminitis that is clearly necessary for any 
relevant induction model is the inflammatory response. This is because it has been 
noted that hoof wall temperature is increased in animals with both natural and 
induced cases of laminitis (Baxter 1994). Work has been done to look at  the 
expression of IL-1β, an inflammatory cytokine, in the laminae of horses 
administered BWE after approximately 3 hours (Fontaine, Belknap et al. 2001). 
The results showed an increase in IL-1β which provided evidence of an 
inflammatory response occurring early in the development of BWE laminitis. 
Other pro-inflammatory cytokines such as IL-6 and IL-8 have been observed to be 
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increased in the CHO and BWE models of laminitis, once again indicating that 
laminitis in accompanied by an inflammatory response (Belknap, Giguere et al. 
2007). These results have only been investigated in induction models of laminitis 
and it is critical to see if these same results are found in animals with naturally 
occurring laminitis.  
The most commonly used methods for induction of laminitis by 
Carbohydrate Overload was developed in 1975 (Garner, Coffman et al. 1975). A 
laminitis inducing ratio of 85% corn startch and 15% wood cellulose flour was 
administered at a dose of 17.6g/kg body weight via a stomach tube. It has been 
observed that there is an alteration in cecal flora, lactic acidosis, and endotoxemia 
after administration but the exact mechanism of laminitis induction is still 
unknown (Garner, Moore et al. 1978; Moore, Garner et al. 1979; Krueger, Kinden 
et al. 1986; Sprouse, Garner et al. 1987; Weiss, Evanson et al. 1998; Weiss, 
Evanson et al. 2000). Obel Grade 3 lameness was observed approximately 40 
hours post CHO treatment. Increased packed cell volume, leukocytosis, and 
hyperproteinemia were all observed in these animals indicating a close relation to 
natural laminitis (Coffman and Garner 1972; Harkema, Robinson et al. 1978; 
Moore, Garner et al. 1981; Fagliari, McClenahan et al. 1998).  
 Examination of the hoofs histology in the CHO model has shown that 
there is an initial alteration in the digital vasculature, including swelling of 
endothelial cells and mild edema formation (Hood, Grosenbaugh et al. 1993). 
After 6-12 hours of administration a leukocyte infiltration occurs that dissipates as 
inflammatory cells are able to migrate to the epidermal layer. Microvascular 
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thrombi and accompanying severe edema formation are seen after 24 hours, and 
hemorrhage occurs in the primary dermal layer after 72 hours (Hood, 
Grosenbaugh et al. 1993). It has also been observed that after 48 hours of CHO 
treatment the lamellar basement membrane disintegrates and attachment of the 
basement membrane to basal cells of the epidermis is gone (Pollitt 1996).  
Treatment 
 
 To date there is no cure for laminitis but there are several treatment 
options. In many cases rest and corrective shoeing is what an owner will do to 
curb a laminitic episode. Shoes will typically have pedal bone support to keep the 
p3 bone in the proper position to aide readhesion. In many other cases analgesics 
and vasodilators are used to relieve pain, reduce inflammation, and improve blood 
flow to the hoof. It is thought that increasing blood flow to the hoof area will help 
to speed the influx of repair enzymes to the area. Since there is no cure these 
treatments are only supplementary to the animals own immune system which 
overall has to take on the task of repairing any damage to the laminae.  
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CHAPTER III 
 
HISTORY OF ADAMs AND RELATED METALLOPROTEASES 
   
ADAM discovery 
 
 The ADAM family of proteins was initially discovered as a cellular family 
of proteins that share a common domain organization with the previously 
discovered snake venom metalloproteases (Weskamp and Blobel 1994; 
Wolfsberg, Primakoff et al. 1995).  
 
Domain Organization 
 
 ADAMs are members of the zinc protease superfamily which is 
subdivided based on their catalytic sites primary structure. This group of 
metalloproteases belongs to the metzincin subfamily which is further divided into 
adamlysins (matrixins belong to this family as well MMPs and ADAM-TS) 
(Wolfsberg, Primakoff et al. 1995). The typical organization of an ADAM from 
n-termini to c-termini is a signal sequence, a prodomain, metalloprotease domain, 
disintegrin domain, cystine rich repeats, an EGF like domain and a 
transmembrane domain with a cytoplasmic tail afterwards (Seals and Courtneidge 
2003).  
 The ADAM-TS subfamily share a very similar organization to that of the 
ADAMs with a signal sequence, prodomain, metalloprotease domain, disintegrin 
domain followed by a single thrombospondin like domain followed by a cysteine 
rich domain (Seals and Courtneidge 2003). This is then followed by varying 
numbers of thrombospondin like repeats depending on the exact ADAM-TS being 
discussed.  
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 MMPs, a group of metalloproteases belonging to the same family as the 
adamlysins share a similar domain organization to that of ADAMs. Typical 
organization for the MMPs is a signal sequence, a prodomain, metalloprotease 
domain with fibronectin type II like repeats, and a hemopexin like domain (Seals 
and Courtneidge 2003). A schematic representation of these domains can be 
found in Figure 2.  
 TIMPs, the natural Tissue Inhibitors of Metalloproteases have four family 
members, TIMP1-4. This family of proteins has two domains, an N-terminal 
domain and a C-terminal domain (Woessner 2001). Each domain contains three 
disulfide bridges and most of the biological functions reside in the N-terminal 
domain (Brew, Dinakarpandian et al. 2000).  
 
 (Seals and Courtneidge 2003) 
 
Figure 2 – Domain Organization of ADAM Family of Metalloproteases 
Domains of the ADAMs and related metalloproteases. ADAMTS family members 
have variable number of thrombospondin-like (TS) repeats. MMP shown is 
representative of the gelatinase class (MMP-2 and 9). 
 
Expression, Regulation, and Localization 
 
 The expression pattern of the ADAM family of proteins is greatly varied 
with many of these proteins being expressed in the testis (Seals and Courtneidge 
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2003). These proteins are thought to be synthesized in the rough ER and then go 
on to mature in the late Golgi compartment (Lum, Wong et al. 1999; Hougaard, 
Loechel et al. 2000; Howard, Maciewicz et al. 2000). It is while the protein is in 
the late Golgi that the pro domain is thought to be cleaved, making the protein 
competent to function. Cleavage of the pro domain can also occur at the cell 
surface by furin-like proteases (Srour, Lebel et al. 2003). Metalloprotease activity 
of ADAMs 10, 17, and 19 can occur within intracellular compartments 
(Skovronsky, Moore et al. 2000; Shirakabe, Wakatsuki et al. 2001). With all of 
these differences in localization it is presumed that the localization and activity of 
ADAMs depends on the cell type, substrates, and which ADAM is interacting.    
 The ADAM-TS family of proteins has been shown to localize within the 
ECM. This localization is mediated via the thrombospondin (TSP) repeats which 
can bind to ECM components. The tissue distribution for each ADAMTS family 
member is wide spread in normal adult tissues. A table of the ADAM-TS genes of 
interest in laminitis and their tissue localizations in humans can be found below in 
Table 2. The regulation of this gene family is not very well understood but there is 
some evidence suggesting that many of these family members are regulated by 
growth factors, hormones and inflammatory cytokines (Miles, Sluka et al. 2000; 
Wang, Wang et al. 2003; Kashiwagi, Enghild et al. 2004).  
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Gene Fetal Tissue Normal Adult Tissue 
ADAM-TS1 Kidney, Lung Heart, Placenta, Liver, Skeletal Muscle, 
Kidney, Thyroid, Adrenal Cortex, Stomach, 
Bladder, Aorta, Colon, Prostate, Spinal Cord 
ADAM-TS4 Not tested Bladder, Brain, Ovary, Heart, Skeletal muscle, 
Uterus, Stomach, Spinal cord 
ADAM-TS5 Not tested Bladder, Cervix, Oesophagus, Placenta, Uterus 
 
Table 2: Localization of ADAMTS Gene Expression. Adapted from (Porter, Clark 
et al. 2005) 
 Matrix Metalloproteases expression is mostly ubiquitous and therefore 
these enzyme are involved in many physiological processes (tissue remodeling in 
pregnancy, wound healing, and angiogenesis) and pathological conditions 
(cancer, arthritis, periodontitis) (Yan and Boyd 2007). These metalloproteases are 
also capable of degrading the ECM components. This activity is what allows the 
MMP family to remodel and repair defective tissues to allow for normal growth. 
MMPs are primarily regulated by their natural inhibitors, TIMPs (Cawston, 
Billington et al. 1999). This family of metalloproteases has been shown to localize 
to the cartilage of patients with arthritis, suggesting their role in inflammatory 
diseases (Koolwijk, Miltenburg et al. 1995). Their presence is typically linked to 
tissues undergoing remodeling. This is also the case in the joints of horses with 
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osteochondritis dissecans, a disease in which there is a loss of blood supply to the 
area of bone directly beneath the joint (Al-Hizab, Clegg et al. 2002).  
 TIMP expression is widespread. TIMP2 expression is constitutive and 
widely expressed in many tissue types while the rest of the family members are 
inducible proteins and are known to exhibit tissue specificity (Brew, 
Dinakarpandian et al. 2000). TIMP1 is enriched in reproductive organ systems; 
TIMP3 is enriched in the heart, kidney, and thymus (Leco, Apte et al. 1997; 
Crocker, Pagenstecher et al. 2004).  
Substrate Activities 
 
 ADAMs have many substrates and are known to be involved in activities 
such as the shedding of cytokines and cytokine receptors, processing of growth 
factors and their receptors. There have been 30+ ADAMs identified to date and 
19/30 contain the zinc-binding active consensus site of HExxHxxGxxH (Nagase 
and Kashiwagi 2003). One of the best studied ADAMs is ADAM17, better known 
as TNFα converting enzyme, TACE (Black 2002). TNFα is one of the most 
predominant proinflammatory cytokines studied in modern science. Originally 
ADAM17 was found the be the only ADAM capable of processing TNFα in a 
TNFα peptide cleavage assay (Black, Rauch et al. 1997; Moss, Jin et al. 1997). It 
was then seen that TNFα processing still occurred in ADAM17 deficient mice, 
but when an ADAM inhibitor was added to culture this processing stopped, 
suggesting that other ADAMs were processing TNFα (Reddy, Slack et al. 2000). 
It was later found that both ADAM9 and ADAM10 cleave TNFα peptides in vitro 
(Lunn, Fan et al. 1997; Rosendahl, Ko et al. 1997; Roghani, Becherer et al. 1999; 
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Amour, Knight et al. 2000). Even though ADAM17 is not the sole ADAM 
responsible for TNFα processing it is still known as an important element because 
its expression is increased in the inflammatory response (Patel 1999; Colon, 
Menchen et al. 2001). ADAM10 and 17 are also known to cleave the 
chemoattractant fractalkine which is known to function in both adhesion and 
chemoattraction (Rossi and Zlotnik 2000).  
 ADAMs are also believed to have a role in the degradation of the 
extracellular matrix (ECM). ADAM 10 is known to cleave collagen IV in vitro, 
and ADAM15 is capable of cleaving collagen and gelatin in vitro (Chubinskaya, 
Cs-Szabo et al. 1998; Martin, Eynstone et al. 2002). It has also been proposed that 
ADAM15 could degrade ECM either directly through its metalloprotease activity 
or indirectly through proteolytic activation of MMPs (Martin, Eynstone et al. 
2002). ADAM13 also has a known role in ECM modification in xenopus cranial 
neural-crest migration partly due to its ability to cleave fibronectin from the ECM 
(Alfandari, Cousin et al. 2001).  
 ADAMTS proteins are known to function in inflammation, angiogenesis, 
and development (Tang and Hong 1999). Aggrecan, one of the major 
proteoglycans of cartilage, is the primary target of many ADAMTS proteins 
termed aggrecanases. When aggrecan is removed from cartilage the collagen is 
left open to attack by the MMP (Pratta, Scherle et al. 2003). The aggrecanase 
family is made up of ADAMTS-1, 4, 5, 8, 9, and 15. Of these aggrecanases 
ADAMTS4 and 5 are the most studied and the cleavage fragments of aggrecan 
are known (Sugimoto, Takahashi et al. 1999; Tortorella, Pratta et al. 2000; 
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Tortorella, Malfait et al. 2001). These two are also capable of cleaving the 
chondroitin sulfate proteoglycans brevican and versican (Matthews, Gary et al. 
2000; Sandy and Verscharen 2001).  
 The natural substrate of the TIMP family of proteins are other 
metalloproteases such as ADAM, ADAMTS and MMPs. TIMP1 and TIMP2 are 
able to bind to both pro-MMP9 and pro-MMP2 via their C-terminal hemopexin 
like domain (Apte, Olsen et al. 1995; Gomez, Alonso et al. 1997; Olson, Gervasi 
et al. 1997; Olson, Bernardo et al. 2000). Binding via the C-terminal domain is the 
most common way in which TIMPs interact with the pro-MMPs to regulate them. 
TIMP2 and TIMP4 can bind pro-MMP2 and inhibit MMP2 and MT1-MMP 
activity (Hernandez-Barrantes, Shimura et al. 2001). The C-terminal domain of 
TIMP3 mediates its binding to the ECM while the other members in the TIMP 
family are only found in soluble forms (Langton, Barker et al. 1998). TIMP3 is 
also able to inhibit several members of the ADAM and ADAMTS families 
including ADAM10, ADAMTS4 and 5 (Smith, Kung et al. 1997).   
 The Matrix Metalloprotease (MMP) family substrate activities are 
categorized into six categories. These include the collagenases, gelatinases, 
stromelysins, matrilysins, membrane-type MMPs, and then the ‘orphan’ MMPs 
which do not fall into any of the above categories. Each subsets name essentially 
identifies its substrate. The main family of interest in laminitis is the gelatinase 
family due to their known presence in laminitis animals (Kyaw-Tanner and Pollitt 
2004; Loftus, Belknap et al. 2006).  
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The gelatinases, made up of MMP2 and MMP9, have an additional 
fibronectin domain inside the catalytic domain. This domain is potentially 
responsible for their ability to digest denatured collagen or gelatin (O'Farrell and 
Pourmotabbed 1998). MMP2 is capable of degrading types IV, V, VII, and X 
collagen, elastin, fibronectin, laminin, and several chemokines. This MMP is also 
capable of activation of proMMP1 and proMMP9 (Yu, Sato et al. 1998). MMP9 
also has a type V collagen like sequence between the catalytic and hemopexin like 
domains. This MMP is capable of degrading denatured collagen, types IV, V, and 
XI collagen, aggrecan, and elastin (Visse and Nagase 2003).  
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CHAPTER IV 
 
IMPLICATION OF ADAMs AND RELATED METALLOPROTEASES IN  
 
EQUINE LAMINITIS 
 
Functions of MMPs in Laminitis 
 
 Matrix Metalloproteases were first identified as proteins of interest in 
laminitis in 1996 when C.C.Pollitt suggested that the expression and activation of  
MMPs was the mechanism causing the separation of the epidermal and dermal 
laminae (Pollitt 1996). Johnson et al (Johnson, Tyagi et al. 1998) then analyzed 
laminae tissue samples from laminitic and non-laminitic horses. This group 
discovered that there was gelatinase activity at 92 kDa, 72 kDa, and 66 kDa which 
corresponds to MMP9, and MMP2 respectively. This discovery both confirmed 
what Pollitt had suggested and initiated a new hypothesis on the overall events 
leading to the degradation of the laminae. Previous to this study, work had 
focused mainly on the histopathological abnormalities within the epidermal 
laminae and not in abnormalities developed in the collagen of the basement 
membrane and the ECM of the dermis.   
 Since this discovery there has been much focus on the involvement of 
MMPs in both natural and experimentally induced laminitis. The activation of 
endogenous MMP2 and MMP9 activity has been shown to reduce the tensile 
strength of laminar explants in vitro (Mungall, Pollitt et al. 1998). MMP2 has also 
been shown to be localized to the cytoplasm of the basal and parabasal cells 
which are in close proximity to the lamellar basement membrane using in situ 
hybridization. Along with that result it was shown that MMP2 mRNA is 
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significantly elevated in laminitic horses using qPCR (Kyaw-Tanner and Pollitt 
2004). Studies have also been done on the concentrations of collagen IV, a known 
target of MMP2 and 9, in horses with laminitis. The results showed that there was 
an increase in collagen IV in serum of horses with natural laminitis which 
matched up with elevated MMP tissue activity indicated by more gelatin 
degradation in a gelatin zymography assay (Johnson, Kreeger et al. 2000). In the 
BWE model of laminitis MMP9 increase has been correlated to immigration of 
neutrophils into the laminae (Loftus, Belknap et al. 2006). Since neutrophils are 
known to store mature MMP9 in their tertiary granules it is not necessary for its 
transcription in order to observe its accumulation (Chakrabarti and Patel 2005). 
While these are promising data, it is essential to note that gel zymogram do not 
reflect the true activity of MMP in vivo as the SDS-PAGE removes the 
prodomain artificially activating the enzyme. While these experiments are 
indicative of the relative abundance of each MMP, more experiments are needed 
to detect active MMP in situ. 
Role of ADAMs in Laminitis 
 
 ADAMs are known to have a prominent role in both inflammatory disease 
and cartilage degradation (Moss and Lambert 2002; Nagase and Kashiwagi 2003). 
ADAMs are known to be up regulated at the site of inflammation and their roles 
as sheddases is potentially critical during this process. ADAM17 (TACE) is the 
most studied ADAM in inflammatory diseases and the exact cleavage sequence is 
known (Black, Rauch et al. 1997; Itai, Tanaka et al. 2001; Moss and Lambert 
2002). ADAM10 is also known to process pro-TNFα, suggesting it also may 
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complement the activities of ADAM17 (Lunn, Fan et al. 1997). Both ADAM10 
and 17 are also able to cleave the chemoattractant fractalkine which functions in 
both adhesion and chemoattraction (Rossi and Zlotnik 2000). These two ADAM 
are therefore likely candidate to be increased in the model of laminitis derived 
from inflammation. 
 
 The ADAM-TS family of proteases also has a potential role in laminitis 
disease progression based on their ability to cleave and process aggrecan, a 
proteoglycans found in many ECMs (Nagase and Kashiwagi 2003; Porter, Clark 
et al. 2005; Gendron, Kashiwagi et al. 2007). ADAMTS-1, 4, and 5 are all known 
aggrecanases and their presence in the laminae could be a critical step is 
determining the molecular pathology of laminitis. The presence of these proteases 
would suggest that laminitis may bear closer resemblance to arthritis than to any 
other human diseases and could have implication in the development of a disease. 
 The TIMP family of inhibitors is also an interesting target, as the members 
of this family are able to inhibit all of the ADAMs mentioned above. The affinity 
of certain TIMPs is higher for certain ADAMs so it will be interesting to 
determine how the expression levels are changed in each individual case.  
 The goal of this gene selection is to evaluate how the overall proteolytic 
activity may change during the onset and evolution of laminitis. 
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Working Model of Proteolytic Cascade Leading to Degradation of Collagen  
 
and Aggrecan 
 
 We have used the knowledge accumulated on MMP and ADAM to draw a 
diagram that describes how they may be involved in the degradation of the ECM 
Laminae. (Figure 3),. Upon the initial damage it is possible that either ADAM10 
or ADAM17 could be activated. These molecules are capable of processing pro-
TNFα to its active form TNFα (Rosendahl, Ko et al. 1997). Once this potent 
cytokine has been activated it is capable of activating several pathways which all 
ultimately lead to the potential degradation of the laminae. The first of these 
pathways is the activation of the ADAMTS family of aggrecanases which could 
degrade aggrecan present in the laminae. The second pathway that could be 
activated is the MMP pathway. Both MMP2 and 9 are capable of degrading type 
IV collagen which is known to be present in the laminae (Kuwano, Ueno et al. 
2005). The activation of both families of these proteases could lead to the 
separation of the laminae, causing laminitis disease progression. On the other 
hand, the TIMP family of protein is able to inhibit many of these pathways at 
several points. TIMP3 is capable of inhibiting both ADAM10 and 17, as well as 
the ADAMTS family of aggrecanases (Smith, Kung et al. 1997) . TIMP1 is 
capable of inhibiting MMP9 and TIMP2 is capable of inhibiting both MMP2 and 
9 (Apte, Olsen et al. 1995; Gomez, Alonso et al. 1997; Olson, Gervasi et al. 
1997).  
 In order to test this model we have cloned and sequence members of the 
ADAM, ADAMTS, TIMP and MMP family of proteins. We the used these 
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sequence to study variation in gene expression during the progression of natural 
and artificially induced laminitis.  
 
 
Figure 3: Model of a proteolytic cascade that could lead to the development of 
laminitis. 
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CHAPTER V 
 
CLONING OF ADAMs 
 
Cloning and Sequencing of Equine ADAM10, 17, TS4, TS5 and  
 
MMP9 
 
In order to study the role of the ADAM family of proteins in equine 
laminitis, ADAM10, ADAM17, ADAM-TS4, and ADAM-TS5 needed to be 
cloned. To accomplish this, multiple protein sequence alignments were done for 
each gene between several mammalian species in order to determine regions of 
homology (Figures 4-7). Degenerated oligonucleotide primers were designed for 
each genes most homologous region and are denoted by the boxed sequences in 
Figures 4-7. Each of these figures represents a ClustalW alignment of the equine 
sequence with three other mammalian species. Identical residues are denoted by 
an asterix (*), conservative changes by a double point (:). Also these figures 
display the locations of the real time PCR primers which are shown with arrows. 
Since ADAMs are known to be expressed in the testis (Wolfsberg, Straight et al. 
1995; Kim, Kang et al. 2006) cDNA was made from equine testis tissue. Each 
primer set amplified its expected size bands, which were cloned into pCR4-TOPO 
(Invitrogen) for sequencing. These results, compared with the human sequences 
showed that ADAM10 is 95% identical, ADAM17 is 91% identical, full length 
ADAM-TS4 is 90.8% identical, and ADAM-TS5 is 91% identical. Each cloned 
sequence corresponded to a different region of domains, which can be seen in 
Figures 4-7.  
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Figure 4: Amino Acid Sequence Comparison of Equine ADAM10 
 
Single letter amino acid sequence from equine, human, bovine, and mouse 
ADAM10 were aligned using ClustalW software. Identical residues denoted by an 
asterisk (*), conservative changes are indicated by a double point (:). The 
sequence corresponding to the degenerate oligonucleotides are indicated in boxes. 
Position corresponding to the oligonucleotide primers used for qRT-PCR 
indicated by arrows. The domains are separated by vertical lines. 
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Figure 5: Amino Acid Sequence Comparison of Equine ADAM17  
 
Single letter amino acid sequence from equine, human, rat, and mouse ADAM17 
were aligned using ClustalW software. Identical residues denoted by an asterisk 
(*), conservative changes are indicated by a double point (:). The sequence 
corresponding to the degenerate oligonucleotides are indicated in boxes. Position 
corresponding to the oligonucleotide  primers used for qRT-PCR indicated by 
arrows. The domains are separated by vertical lines. 
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Figure 6: Amino acid sequence comparison of Equine ADAMTS-4 
Single letter amino acid sequence from equine, human, bovine, and mouse 
ADAMTS-4 were aligned using ClustalW software. Identical residues denoted by 
an asterisk (*), conservative changes are indicated by a double point (:). The 
sequence corresponding to the metalloprotease active site is indicated in a box. 
The positions corresponding to the oligonucleotide primers used for qRT-PCR are 
indicated by arrows. The domains are separated by vertical lines.  
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Figure 7: Amino acid sequence comparison of Equine ADAMTS-5 
 
Single letter amino acid sequence from equine, human, bovine, and mouse 
ADAMTS-5 were aligned using ClustalW software. Identical residues denoted by 
an asterisk (*), conservative changes are indicated by a double point (:). Sequence 
corresponding to degenerate oligonucleotides is indicated in a box. Active 
metalloprotease site is also labeled and presented in a box. Position corresponding 
to oligonucleotide primers used for qRT-PCR is indicated by arrows. The 
domains are separated by vertical lines.   
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The specific fragments obtained by amplification  are shown in Figure 8. 
The positions of these primers can also be seen in Figures 4-7. For each of these 
primer sets, PCR amplification was performed using no-RT controls, Genomic 
DNA, and cDNA samples to test 1) that the cDNA did not contain contaminating 
genomic DNA, 2) if the primer could amplify from genomic DNA.  
 
Figure 8: PCR Amplification of +/-RT cDNA Using Specific  
 
Oligonucleotide qPCR Primers 
 
Degenerate primers and those used for the amplification of full length and 
partial clones can be found in Table 3. A table that shows the primer efficiencies, 
slope and R
2
 values, as well as the specific melting temperatures of the 
amplification product as determined by running a melting curve can be found in 
Table 4.  
 35 
 
Table 3: Primer Pairs Used for Specific Gene Amplification and for qRT-PCR 
 
 
Table 4: qRT-PCR Amplification Efficiencies 
 
Testis cDNA was diluted in 10 fold increments in sterile H2O from a 1:1 to a 
1:100 dilution to create templates for the generation of a standard  curve for each 
gene tested. Efficiencies between 85-110% along with a slope between -3.0 and -
4.0 and an R
2
 value between 0.90 and 1 were acceptable as being equal in 
efficiencies. 
 
 
 
 
 
 36 
 
 
Table 5: Oligonucleotide Primer Sets Used for Cloning ADAMs 
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CHAPTER VI 
 
EXPRESSION OF ADAM RELATED METALLOPROTEASES 
 
IN BWE INDUCED LAMINITIS 
 
Animals Used 
 
 For the BWE experiments, archived samples of laminar tissue from 
previous studies were used (Waguespack, Cochran et al. 2004; Waguespack, 
Kemppainen et al. 2004; Black, Lunn et al. 2006).  
 
Real Time PCR Results 
 
In the BWE model of laminitis, Table 6A, it was observed that ADAM10 
and ADAM17 were more likely to be decreased than increased. ADAM10 
expression was decreased in 5/8 animals with 2 animals showing no change and 
one animal showing a slight increase at the 3 hour time point. ADAM17 was 
decreased in 3/8 animals and no change was seen in 4/8 animals with one animal 
showing a slight increase in expression at the 3 hour time point. ADAM-TS1 was 
slightly increased in 5/8 animals with the remainder showing no changes in 
expression. ADAM-TS4 was the most induced gene of this study and every 
animal showed at least a slight increase with most animals (6/8) showing a large 
increase in expression. ADAM-TS5 was decreased in this study in 3/8 animals 
with the remainder showing no change. MMP9 reduction seemingly occurred at 
the early time point of 1.5 hours with 2/2 animals showing a decrease. TIMP1 
expression was not seen to change other than 1/8 animals showing a 2.13 fold 
increase. TIMP2 expression was reduced in 5/8 animals with no trend towards 
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either early or late reduction. Expression of TIMP3 was not changed at the early 
time point, however 5/6 animals at the 3 hour and 12 hour time points showed a 
reduction in expression. 
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CHAPTER VII 
 
EXPRESSION OF ADAM RELATED METALLOPROTEASES 
 
IN CHO INDUCED LAMINITIS 
 
Animals Used 
 
 For the CHO experiments, archived samples of lamellae from a previous 
study were used (Johnson, Kreeger et al. 2000).  
 
Real Time PCR Results 
 
  The CHO model of laminitis, Table 6B, was grouped into animals which 
either showed a response to treatment (CHO-R), and those which did not (CHO-
NR). Animals which were in the CHO-R group showed no changes in either 
ADAM10 or ADAM17 expression, while there was an increase in expression of 
ADAM-TS1. ADAM-TS4 was greatly increased in 3/3 animals in the CHO-R 
group, and also in 2/3 animals in the CHO-NR group. ADAM-TS5 expression 
was also increased in both the CHO-R and CHO-NR groups with 5/6 animals 
showing an increase. MMP9 was consistently induced in all 6/6 animals in the 
CHO study. TIMP1 expression was also increased in 5/6 animals in the CHO-R 
and CHO-NR groups. TIMP2 was decreased in the CHO-R group while there was 
no change seen for the animals in the CHO-NR group. TIMP3 was increased in 
all of the horses in the CHO-NR group while there were 2/3 horses with an 
increase in the CHO-R group, with the remaining animal showing a decrease in 
expression.  
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CHAPTER VIII 
 
EXPRESSION OF ADAM RELATED METALLOPROTEASES 
 
IN NATURAL LAMINITIS 
 
Animals Used 
 
 The natural laminitis samples were obtained from horses which were 
euthanized at the University of Missouri School of Veterinary Medicine Equine 
Clinical Center.  
 
Real Time PCR Results 
 
  Natural cases of laminitis, Table 6B, share the best correlation of gene 
expression with the CHO model. This model had animals grouped into either 
acute cases in which the animals had not previously shown signs of laminitis, 
animals in the chronic subset had a history of laminitis but had not had any acute 
episodes, and animals in the chronic aggravated subset had a history of laminitis 
and were experiencing a debilitating episode. All horses, regardless of 
classification, showed an increase in ADAM-TS4 expression and 9/11 showed a 
decrease in TIMP2 expression. ADAM10 expression was decreased in both the 
chronic and chronic aggravated animals (4/8) with the remainder showing no 
change in expression. ADAM17 showed no change in expression, with the 
exception of one clinical animal having a decrease. ADAM-TS1 only had 3/11 
animals with slight increases while ADAM-TS5 expression was increased in 
acute cases as well as 5/8 of the chronic and chronic aggravated cases. MMP9 
expression was greatly increased in the acute cases of laminitis while there were 
6/8 animals with an increase in the chronic and chronic aggravated cases of 
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laminitis. Expression of TIMP1 was increased in acute cases while there was 
either no change or a decrease in expression in the chronic and chronic aggravated 
cases. Expression of TIMP3 was increased in all animals in the clinical cases and 
expression ranged from 3.2 to 31.76 fold increase.  
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Table 6: Quantative Real Time PCR Results 
 
Real-time quantative PCR was performed on cDNA samples of 32 horses.  Each 
specific oligonucleotide primer pair was run in triplicate on three  different days 
using a Roche Lightcycler 2.0. The relative value for each  sample was obtained 
using the ∆∆Ct method and controlled to expression of GAPDH. Each value was 
averaged from triplicates. Numbers between 2 and 10 are highlighted in yellow 
and correspond to a 2 to 10 fold increase. Numbers superior to 10 are in red and 
correspond to an increase greater than 10 fold. Values inferior to 0.5 are 
highlighted in blue and correspond to at least a 2 fold decrease. The horse 
number, age, breed, as well as the results for each of the selected genes are 
presented. BWE; Black Walnut Extract, CHO; Carbohydrate Overload.  
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CHAPTER IX 
 
SUMMARY OF RESULTS 
 
 These results show that ADAMs which are known to be associated with 
inflammation, ADAM10 and ADAM17, are not significantly increased in horses 
with laminitis, regardless of the mode of induction (BWE, CHO, natural) and the 
extent of disease. These two genes also clearly act independently of one another, 
as it was observed that an increase in one did not necessarily result in an increase 
of the other.  
 The most consistently increased gene in this study, independent of the 
mode of induction, was ADAM-TS4 with 24/25 animals showing an increase 
which ranged from 2 fold to 333.14 fold increase. The CHO model, acute 
laminitis cases, and BWE 3 hour animals all had a significant increase over 10 
fold. In many of these cases, the disease was well developed but the increase at 
the early BWE time point of 1.5 hours indicates that this ADAM is being induced 
before lameness occurs and then remains activated at very high levels throughout 
disease progression. TIMP2, the natural inhibitor of MMP2, was decreased in 
16/25 horses, which could play a role in the eventual degradation of the laminae 
since MMP2 is known to be increased in horses with laminitis (Kyaw-Tanner and 
Pollitt 2004). When the observation is limited to horses with clinical signs (12 
hour BWE samples, CHO-R, and all clinical cases), 14/17 horses showed a 
decrease in TIMP-2. The expression of TIMP1 seemed to be randomly increased 
or decreased with no real trends visible. TIMP3 expression was decreased in 5/8 
animals in the BWE model while it was increased in 16/17 horses in the CHO and 
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clinical cases. This is an interesting fact considering that TIMP3 is an inhibitor of 
ADAM10, ADAM17, and ADAM-TS1, 4, and 5. This increase could be a 
response of the laminae to try and stop the progression of the disease. 
 When you look at each induction subset which was investigated the results 
are much more interesting considering that the BWE model is known to be a 
model of early and reversible laminitis while the CHO model is more like that of 
a clinical case of laminitis. In the BWE model Table 6A, ADAM-TS4 was the 
only gene that was induced in every animal. MMP9 was initially reduced in the 
1.5 hour and 3 hour animals, while TIMP2 was reduced at the later time points of 
3 hours and 12 hours. TIMP3 was also reduced in 5/8 horses and its reduction 
occurred mainly in the late stage animals. These results, which show that this 
model may in fact be an early and reversible form of laminitis, could help to make 
use of this model to understand how the reversion of disease is occurring. In this 
case, ADAMTS-4 increase would be at the onset of the development of the 
disease preceding all other MMP.  
 In the CHO induction model, Table 6B, there were horses which were 
responders, CHO-R, and horses which did not respond to the treatment, CHO-NR. 
The CHO-R group showed increased levels of ADAM-TS1, 4, 5, MMP9 and 
TIMP1 with a slight decrease in TIMP2 expression. The CHO-NR group had only 
1/3 animals with an increase in ADAM-TS1, 2/3 animals with an increase in 
ADAM-TS4 and TS5 and all had a similar increase in MMP9. This result 
suggests that ADAM-TS4 and TS5 are directly linked to the progression of 
laminitis even with the increase of TIMP3 that was observed in 5/6 animals in this 
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group. TIMP2 was also reduced in 2/3 CHO-R animals which is similar to the 
result which was observed in the BWE model at the late time points.  
 In the clinical laminitis cases, Table 6B, there was a strong correlation of 
results to those observed in the CHO model. All animals in this group showed an 
increase of ADAM-TS4 expression from 2.73 to 333.14 fold induction. MMP9 
was also increased in this group in 9/11 animals and a decrease in TIMP2 was 
observed for 9/11 animals as well. There was no change observed in expression of 
ADAM17 with the exception of one animal showing a slight decrease. ADAM10 
expression was overall unchanged in the acute and chronic cases of laminitis 
while it was decreased in 3/4 of the chronic aggravated animals. TIMP3 
expression in this group was seen to increase in all cases of the disease suggesting 
that it is potentially being increased in response to the influx of the ADAM-TS 
proteins.  
 A broad overview of these results indicates that there are several key 
targets for further study. ADAM-TS4, which is seen to have increased 
transcription in 24/25 animals, regardless of the induction method, is a likely 
target for the treatment of laminitis. The expression of TIMP2 also brings to 
question its importance in the progression of disease considering that it has 
decreased expression in 16/25 animals in this study. The high expression levels of 
MMP9 are also of interest in this disease, and have been the target of many 
studies in the past (Mungall, Pollitt et al. 1998; Mungall and Pollitt 1999; Mungall 
and Pollitt 2002; Loftus, Belknap et al. 2006; Loftus, Black et al. 2007). Recent 
work on MMP9 suggests that this accumulation of MMP9 is a downstream event 
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of the initial inflammation and activation of endothelial cells (Loftus, Black et al. 
2007).  
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CHAPTER X 
 
DISCUSSION 
 
 The initial focus of this project was on ADAM10 and ADAM17 (TACE) 
because they are both capable of processing TNFα which is one of the pro-
inflammatory cytokines potentially playing a role in laminitis. The results 
obtained showed no real dramatic changes in the expression of these genes in all 
modes of induction. Increases observed in both TIMP1 and 3, inhibitors of these 
ADAMs, suggests that the activity of these proteins is likely reduced causing a 
decrease in TNFα processing. Another study by Belknap et al (Belknap, Giguere 
et al. 2007) where TNFα mRNA was measured by qPCR and no significant 
increase was observed, suggest that TNFα  is not likely to be essential for the 
progression of the disease.  
 Previous work on laminitis has mainly targeted two proteins, MMP2 and 
MMP9. These two metalloproteases have been seen in multiple instances to be 
increased depending on the mode of induction of laminitis. MMP9 protein was 
shown to be induced up to Obel grade 1 lameness in the BWE model (Loftus, 
Belknap et al. 2006) and both MMP2 and 9 are induced in the CHO model 
(Kyaw-Tanner and Pollitt 2004). The expression of MMP9 mRNA was confirmed 
in the CHO model in this study but results are not concrete in the BWE model.It 
is possible that the difference observed for MMP9 expression in this study 
compared to the previous is the choice of gene selected for the normalization 
(GAPDH versus β2-Microglobulin). We are confident that the results obtained in 
this study are accurate since in the same conditions, the MMP9 mRNA 
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quantification for the CHO was confirmed by a similar increase in MMP9 protein 
level obtained from the same horses tested by Dr. Black and colleagues. . One 
interesting factor that was common throughout all modes of induction and disease 
progression is that TIMP2 was frequently reduced in 16/24 animals. TIMP2 is 
responsible for the inhibition of both MMP2 and MMP9 and its decreased 
expression could allow for an increase in MMP activity even in the absence of an 
increase in MMP mRNA and protein expression in the laminae to cause damage 
to the laminae (Gomez, De Lorenzo et al. 1999; Nagase, Visse et al. 2006).  
 The most obvious gene which was consistently upregulated independently 
of the method of induction was ADAM-TS4. This protein is considered to be one 
of the main factors involved in cartilage remodeling and osteoarthritis pathology 
(Malfait, Liu et al. 2002; Song, Tortorella et al. 2007). In cartilage ADAM-TS4 
and 5 cleave aggrecan whose function is to provide a mechanical resistance to 
compressive loads. This resistance is provided by the overall negative charges on 
the polysaccharide side chains. These negative charges create an osmotic 
environment that allows for the high osmotic swelling pressure of cartilage. This 
pressure is counteracted by resistance of intact collagen fibers which in turn 
creates the high tensile strength.  
 Aggrecanase in cartilage is known to be induced by several cytokines such as IL-
1, IL-6, and TNFα (Tortorella, Malfait et al. 2001). There are also reports of its induction 
by fibronectin fragments (Homandberg, Meyers et al. 1992; Stanton, Ung et al. 2002). All 
of the above cytokines have been observed to be induced in both a BWE and CHO 
induction model (Belknap, Giguere et al. 2007) and could be contributing factors to the 
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large increase of ADAM-TS4 that was observed. The induction of ADAM-TS4 by 
fibronectin or by the previously mentioned cytokines still remains to be determined.  
 The most potent natural inhibitor of ADAM-TS4 is TIMP3 (Hashimoto, 
Aoki et al. 2001). The remaining members of the TIMP family are known to have 
a higher affinity for the MMPs (Clegg, Coughlan et al. 1998; Kashiwagi, 
Tortorella et al. 2001; Cross, Chandrasekharan et al. 2005). There is clearly an 
association between the decrease in TIMP3 and disease progression in the BWE 
model (5/8 animals) but this is not as evident in the natural and CHO induced 
laminitis cases. There are several animals that had a poor prognosis and a drastic 
increase in TIMP3 expression. Even with the increased level of this inhibitor 
disease progression is able to continue suggesting that there may be more to 
treatment than finding a way to increase transcription of the TIMPs.  
 Aggrecan is able to protect collagen from degradation by MMPs, but there 
are other ECM proteins like fibronectin and thrombospondin that interfere with 
ADAM-TS4 access and degradation of aggrecan (Tortorella, Pratta et al. 2000; 
Hashimoto, Shimoda et al. 2004). This cooperation could explain why the 
development of laminitis needs activation of both ADAM-TS4 and MMPs. With 
such a focus on the treatment of arthritis in the past couple of years there have 
been several inhibitors developed. These include hydroxamates, P1’ 
biphenylmethyl substituted inhibitors, to inhibit ADAM-TS proteases (Yao, Chao 
et al. 2002; Noe, Natarajan et al. 2005). MMP inhibitors have also been developed 
recently and one is highly selective for the inhibition of MMP-2 (Hayashi, Jin et 
al. 2007). With all of these tools available as potential treatments for laminitis 
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there is clearly a promising area of research to be pursued in both the 
development of a clearly defined pathway for laminitis and in finding a way to 
inhibit the proteases responsible for cartilage degradation without affecting other 
pathways for which these metalloproteases are critical.  
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